Research Website

Hi all,

The research website will definitely go ahead,

with a bit of luck, the main structure will be posted on Monday.--- the tricky bit will be the balance of research and ethical company promotion.

It’s a very fine line that I don’t want tocross. So that’s the main thinking point for me at the moment. – however, we will make it clear that the project that we will feature , ie Oncosil is in need of financial support, a white knight who is willing to support us beyond financial interest.

In the initial stages we have two tiers of locations,

tier one as those who have treatment centres and who are in training, and tier two will be all the others where they areexpected to have progressed soon. Tier 1will have country names and majorcities listed for SEO purposes and then also treatment centres; and tier 2 willonly have countries listed.

I’m currently brainstorming the list of main navigation links in the top bar. It is important to have an ethical balance of research and promotion. – yet we all know that without money the company cannot exist. Part of this effort is also to find an organisation or individual who iswilling to support the project. We know the project is worthy of support.

As mentioned yesterday, we will also promote into the US, L.A., San Fran. And other major hubs.

It will be good, Cheers

2

using clever SEO it will rank on Google in alljurisdictions, starting with AUS,SPN,GER,AUST,FR,UK,TUR,GRE,ITY,USA,JP,UAE andNZ , and followed by key cities in those countries on page 1 of Google forrelevant keywords

we will post all kinds of research that can bequeried by a AI chatbot ie Chat gpt 3.5 or 4.0, anlysed etc across a number ofselected docs; also chatbots in general relating to Oncosils procedure etc,also a growing list of treatment centres as they becomec online ( same as onthe company website)

why all this? - as it was shown today Oncosil issuperior to SBRT and I am frustrated with the lack of recognition of thiscompany;

1

Hi everyone – fellow HotCoppers, investors, and supporters,

After a long time in the making,I’m excited to share an initiative that’s both personally meaningful andpotentially valuable to our community. I’m launching adedicated onlinedocument depository focused on pancreatic cancer research, withOncoSil(ASX:OSL) as the first featured project.

The platform will house acomprehensive archive of documents, media releases, clinical studies, investorupdates, and ASX announcements—all enhanced with AI-powered querycapabilities. This means you’ll be able to:

·Chat directly with key documents(e.g. TGA approvals, clinical trial results, ASXannouncements)

·Ask a chatbot specific questions about OncoSil’s progress,achievements, and milestones

·Search and explore using natural language, not just keywords

The aim is to create a next-geninvestor resource that leverages today’s technology to better understandcomplex, under-covered companies like OncoSil. Marketing and investorengagement remain some of the company's key challenges—this tool is designed tohelp fill that gap by providing clarity, accessibility, and depth.

The depository will be promotedacross social platforms likeX(Twitter), andotherinvestor forumsin Europe, the UK, and the US, to bring global visibility to OncoSil and the fight against pancreatic cancer.

This is ahobby project, and I’ll begin building it this week. It will be dedicated to the memory of my brother-in-law, who passed away from pancreatic cancer in 2019. He was a passionate innovator, and I believe he would be proud of this effort to bring innovation to where it’s needed most.

Stay tuned—more to come soon.